#USA #New York #male fertility #Legacy #Scott Lundy

Legacy Appoints Dr. Scott Lundy as Chief Medical Officer

In a significant move to enhance its clinical strategy and innovation in male fertility care, Legacy has welcomed Dr. Scott Lundy, MD, PhD, as its new Chief Medical Officer. Renowned in the field of reproductive health, Dr. Lundy's role will involve steering Legacy's research initiatives and overseeing vital clinical operations.

Who is Dr. Scott Lundy?

Dr. Lundy comes from a prominent background in reproductive urology, currently serving as the Male Infertility Section Director and Clinical Andrology Lab Director at the Cleveland Clinic's Glickman Urological Institute. His wealth of experience and understanding of male reproductive health makes him a valuable asset for Legacy.

"Dr. Lundy is among the leading physician-scientists in male fertility today," stated Khaled Kteily, Legacy's Founder and CEO. His unparalleled skills in managing complex andrology laboratories and deep knowledge in clinical practices poise Dr. Lundy perfectly to guide Legacy into its next phase of growth.

Expanding Legacy's Product Offerings

Since stepping into his position, Dr. Lundy has made significant strides in broadening Legacy's clinical offerings. Recently, the company introduced an advanced sperm testing platform featuring motility analysis and post-vasectomy semen analysis (PVSA). This innovative mail-in testing service aims to provide fertility clinics and patients with actionable insights, simplifying the process of sperm analysis.

In the near future, Legacy plans to unveil a product providing comprehensive insights about sperm health, further enhancing its research-based approach to male fertility. This aligns with Dr. Lundy's vision to utilize extensive data on male fertility to forge groundbreaking discoveries and clinical applications.

Dr. Lundy's Academic and Research Credentials

Dr. Lundy's academic credentials bolster his role at Legacy. He earned both his MD and PhD from the University of Washington with a focus on regenerative medicine. Following his residency and fellowship at the Cleveland Clinic, he has built a formidable reputation as an expert in male reproductive health.

Unique in his specialty, Dr. Lundy holds the certification as a High Complexity Laboratory Director (HCLD) and supervises numerous laboratories dedicated to andrology and basic science research. His investigations delve into genomic medicine, the microbiome's impact on reproductive health, and the intricacies of sperm functionality in early embryonic development.

His contributions to the field are underscored by over 100 publications and numerous grants from the National Institutes of Health, demonstrating his commitment to advancing knowledge in male fertility. In 2025, he was honored with the Young Reproductive Urologist of the Year Award from the ASRM Society for Male Reproduction and Urology.

A Growing Data Platform

Over the past seven years, Legacy has developed an extensive sperm data framework, recognized as one of the largest in the world. Dr. Lundy’s direction is expected to further amplify research and development efforts—using this invaluable dataset to advance understanding of male fertility and health.

"With tens of thousands of samples analyzed, Legacy's platform is unprecedented. I am excited to help convert this data into actionable clinical insights that will enhance patient care globally," Dr. Lundy remarked.

About Legacy

Legacy stands at the forefront of male reproductive health services in the United States. Offering innovative solutions such as at-home sperm analysis, sperm cryopreservation, and post-vasectomy testing, Legacy aims to redefine male engagement in reproductive health through patient-centric design and clinic-tested methodologies. The company's commitment to enhancing male fertility care is demonstrated through its evolving clinical services and expanding data-driven insights, with Dr. Lundy poised to lead this charge toward innovation and improvement.